Papamargaritis D, le Roux CW, Holst JJ, Davies MJ
This can denature (destroy) the peptide at the air-liquid interface
DOSAGE: A study of TUDCA tested doses of 500 mg, 1000 mg, and 1500 mg per day over six months,and foundthere was little difference between the doses on liver markers*
Scenario C: Biotech With Novel Delivery Platform Seeking to Maximize IP Protection A company developing a new delivery platform an LNP variant with improved endosomal escape efficiency, a new oral peptide absorption enhancer, a responsive polymer for targeted release should structure its patent portfolio with both Orange Book listing and non-listed layers
Shilpa: Liposomes 101 offers a clear look at why liposomes matter for absorption
European Journal of Pharmacology, 570(1-3), 212-221